Clinical Trial Details

Overview

Research Study Summary

Clinical trial for people who have diabetes AND heart problems

Purpose

This clinical trial is provided by Antidote.

The research study is evaluating a new medicine for type 2 diabetes for patients whose diabetes is not well controlled with their current therapy. The study medicine is being evaluated to see if it can help in the management of type 2 diabetes by reducing blood sugar levels.

This study has an online pre-screener.

To Learn more

CW ID: 196521
Date Last Changed: July 24, 2017

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
40 to 100 Years
Overall Status
Recruiting
Lead Sponsor
Merck Sharp & Dohme Corp.
Duration
156 Days
Facility Type
N/A

Eligibility

  • Subjects must be diagnosed with Type 2 Diabetes
  • Subjects must have had cardiovascular disease (diseases that involve the heart or blood vessels)
  • Subjects must not have participated in another clinical research study in the last 3 months
  • Subjects must not be on a weight loss program or taking medications to lose weight

More Info

This study has an online pre-screener.

Contact

This study has an online pre-screener.

Omneon Study Site
Terence T. Hart, M.D.
Located in:
Muscle Shoals, AL 35662

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.